Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-25-016984
Filing Date
2025-10-06
Accepted
2025-10-06 06:05:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 49757
2 GRAPHIC form424b3_001.jpg GRAPHIC 17534
3 GRAPHIC ex10-1_001.jpg GRAPHIC 3201
  Complete submission text file 0001493152-25-016984.txt   79732
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283182 | Film No.: 251375545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)